Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Journal of Pain Research|December 10, 2025
Comparative Cardiovascular Safety of Duloxetine and Gabapentin in Patients with Hip OsteoarthritisSuhyeon Moon, Eunjung Choo, Yeo Jin Choi, et al.
Journal of Global Health|May 24, 2024
Impact of institutional quality improvement initiatives on metabolic monitoring in mental disorder in patients treated with antipsychotics: A meta-analysis of intervention studiesSooyoung Shin, Suhyeon Moon, Jua Wang, et al.
Healthcare (Basel, Switzerland)|February 25, 2022
Tolerability on Serious Adverse Events of First-Line Bevacizumab and Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Systematic Review and Meta-AnalysisYu Na Han, Yeo Jin Choi, Sandy Jeong Rhie
The International Journal of Biochemistry & Cell Biology|September 6, 2013
Stimulation of TRAF6/TAK1 degradation and inhibition of JNK/AP-1 signalling by ginsenoside Rg3 attenuates hepatitis B virus replicationLi-Jung Kang, Yeo-Jin Choi, Seong-Gene Lee
Current Medicinal Chemistry|November 5, 2013
Stimulation of DDX3 expression by ginsenoside Rg3 through the Akt/p53 pathway activates the innate immune response via TBK1/IKKε/IRF3 signallingYeo-Jin Choi, Li-Jung Kang, Seong-Gene Lee
European Journal of Pharmacology|February 9, 2012
Ginsenoside Rh1 suppresses matrix metalloproteinase-1 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathway in human hepatocellular carcinoma cellsJi-Hae Yoon, Yeo-Jin Choi, Seong-Gene Lee
Pharmaceuticals (Basel, Switzerland)|May 27, 2026
Signal Detection and Machine Learning-Based Prediction of Cytokine Release Syndrome in B-Cell Maturation Antigen-Targeting Immunotherapies Using FAERS DataSuhyeon Moon, Dong-Won Kang, Yeo Jin Choi, et al.
British Journal of Clinical Pharmacology|December 17, 2019
Impact of a multidisciplinary quality improvement initiative to reduce inappropriate usage of stress ulcer prophylaxis in hospitalized patientsYeo Jin Choi, Joohyun Sim, Yun Tae Jung, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|May 21, 2026
Clinical Efficacy and Safety Profile of Bimekizumab in Psoriasis: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsSuhyeon Moon, Hye-Young Choi, Yeo Jin Choi, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2021
Incident Type 2 Diabetes Risk of Selective Estrogen Receptor Modulators in Female Patients with Breast CancerYeo-Jin Choi, Keunhyeong Bak, Yoon Yeo, et al.
Pageof 7